Zhibin Zhang

Zhibin Zhang

Auto-generated profile, based on publicly available information

Zhibin Zhang

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SXShiyu Xia
Shiyu Xia
ZZZhibin Zhang
Zhibin Zhang
VMVenkat Giri Magupalli
Venkat Giri Magupalli
JPJuan Lorenzo Pablo
Juan Lorenzo Pablo
YDYing Dong
Ying Dong
HWHao Wu
Hao Wu

2 February 2022 in Nature
Verified
Journal Article
Closed access
PDF file
WDWanyan Deng
Wanyan Deng
YBYang Bai
Yang Bai
FDFan Deng
Fan Deng
YPYoudong Pan
Youdong Pan
SMShenglin Mei
Shenglin Mei
XLXing Liu
Xing Liu

25 June 2021 in Science
Verified
Journal Article
Closed access
PDF file
ZZZengzhang Zheng
Zengzhang Zheng
WDWanyan Deng
Wanyan Deng
YBYang Bai
Yang Bai
RMRui Miao
Rui Miao
SMShenglin Mei
Shenglin Mei
XLXing Liu
Xing Liu
Cell death limits pathogens: During infection, Yersinia inhibition of the protein kinase TAK1 triggers cleavage of the pore-forming protein gasdermin D (GSDMD), which leads to a kind of inflammatory cell death called pyroptosis. In a genome-wide screen, Zheng et al. identified a lysosome-tethered regulatory supercomplex as being a critical driver of Yersinia -induced pyroptosis. The activity of the GTPase Rag and lysosomal tethering of Rag-Ragulator were required to recruit and activate the kinase RIPK1 and protease caspase-8 to cleave GSDMD, which causes cell death and limits infection. By contrast, Rag-Ragulator was not required for inflammasome-mediated pyroptosis. Thus, metabolic signaling on lysosomes can regulate cell death during pathogenic bacterial infection. Science , abg0269, this issue p. eabg0269

28 April 2023 in Science Immunology
Verified
Journal Article
Closed access
QKQing Kong
Qing Kong
SXShiyu Xia
Shiyu Xia
XPXingxin Pan
Xingxin Pan
Kaixiong YeKaixiong Ye
Kaixiong Ye
ZLZhouyihan Li
Zhouyihan Li
ZZZhibin Zhang
Zhibin Zhang
Granzyme A from killer lymphocytes cleaves gasdermin B (GSDMB) and triggers pyroptosis in targeted human tumor cells, eliciting antitumor immunity. However, GSDMB has a controversial role in pyroptosis and has been linked to both anti- and protumor functions. Here, we found that GSDMB splicing variants are functionally distinct. Cleaved N-terminal (NT) fragments of GSDMB isoforms 3 and 4 caused pyroptosis, but isoforms 1, 2, and 5 did not. The nonfunctional isoforms have a deleted or modified exon 6 and therefore lack a stable belt motif. The belt likely contributes to the insertion of oligomeric GSDMB-NTs into the membrane. Consistently, noncytotoxic GSDMB-NTs blocked pyroptosis caused by cytotoxic GSDMB-NTs in a dominant-negative manner. Upon natural killer (NK) cell attack, GSDMB3-expressing cells died by pyroptosis, whereas GSDMB4-expressing cells died by mixed pyroptosis and apoptosis, and GSDMB1/2-expressing cells died only by apoptosis. GSDMB4 partially resisted NK cell-triggered cleavage, suggesting that only GSDMB3 is fully functional. GSDMB1-3 were the most abundant isoforms in the tested tumor cell lines and were similarly induced by interferon-γ and the chemotherapy drug methotrexate. Expression of cytotoxic GSDMB3/4 isoforms, but not GSDMB1/2 isoforms that are frequently up-regulated in tumors, was associated with better outcomes in bladder and cervical cancers, suggesting that GSDMB3/4-mediated pyroptosis was protective in those tumors. Our study indicates that tumors may block and evade killer cell-triggered pyroptosis by generating noncytotoxic GSDMB isoforms. Therefore, therapeutics that favor the production of cytotoxic GSDMB isoforms by alternative splicing may improve antitumor immunity.

21 August 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YZYing Zhang
Ying Zhang
PYPourya Naderi Yeganeh
Pourya Naderi Yeganeh
HZHaiwei Zhang
Haiwei Zhang
SWSimon Yuan Wang
Simon Yuan Wang
ZLZhouyihan Li
Zhouyihan Li
JLJudy Lieberman
Judy Lieberman

18 January 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
QKQing Kong
Qing Kong
ZZZhibin Zhang
Zhibin Zhang
Pyroptosis is a programmed necrotic cell death mediated by pore-forming Gasdermin (GSDM) proteins. After being unleashed from the C-terminal auto-inhibitory domains by proteolytic cleavage, the N-terminal domains of GSDMs oligomerize and perforate on the plasma membrane to induce cytolytic pyroptosis, releasing immune mediators and alarming the immune system. Upon infection or danger signal perception, GSDMD that functions downstream of the inflammasome, a supramolecular complex for inflammatory caspase activation, is cleaved and activated by inflammasome-activated caspase-1/4/5/11 in immune cells and epithelial cells to trigger pyroptosis and exert anti-infection protection. Unlike this inflammasome-activated pyroptosis (IAP), recent studies also suggest an emerging role of cancer-associated pyroptosis (CAP), mediated by other GSDMs in cancer cells, in provoking anti-tumor immunity. IAP and CAP share common features like cell membrane rupture but also differ in occurrence sites, activating mechanisms, secreting cytokines and biological outcomes. Here we review the most recent knowledge of cancer-associated pyroptosis and present a promising avenue for developing therapeutic interventions to enhance anti-tumor immunity for cancer treatment.